psoriasis Archives • NASH & Liver Fibrosis | Galectin Therapeutics

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-content/themes/wp_bullet/inc/ReduxCore/extensions/customizer/extension_customizer.php on line 358

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-content/themes/wp_bullet/inc/ReduxCore/extensions/customizer/extension_customizer.php on line 380

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-content/themes/wp_bullet/inc/ReduxCore/extensions/customizer/extension_customizer.php on line 384

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-content/themes/wp_bullet/inc/ReduxCore/extensions/customizer/extension_customizer.php on line 411

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-content/themes/wp_bullet/inc/ReduxCore/extensions/customizer/extension_customizer.php on line 423

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-content/themes/wp_bullet/inc/ReduxCore/extensions/customizer/extension_customizer.php on line 442
psoriasis Archives • NASH & Liver Fibrosis | Galectin Therapeutics

Photographs of Improvement in Moderate-To-Severe Plaque Psoriasis

0 Comments , in Article

We recently announced positive interim results from an open-label, Phase 2a clinical trial with GR-MD-02 in patients with moderate-to-severe plaque psoriasis (see press release here). On April 28th, I also...

Read More

How Will We Interpret Results from the GR-MD- 02 Psoriasis Trial?

0 Comments , in Article

By Peter G. Traber, M.D. on April 28, 2016 Last September, Galectin Therapeutics began a Phase 2a open-label clinical trial with GR-MD-02, our galectin-3 inhibitor drug, in patients with moderate-to-severe...

Read More

2015 – 2016, Progress and Possibilities

0 Comments , in Article

By Galectin Therapeutics. on January 7, 2016 The many accomplishments at Galectin Therapeutics during 2015 ranged from incremental progress touching every aspect of our business to significant advancements with GR-MD-02. Importantly,...

Read More

Exploratory Indication in Psoriasis

0 Comments , in Article

Written by Peter G. Traber, M.D. on September 24, 2015 Serendipity, or fortunate happenstance, has always been an important part of the search for medicines. As pointed out by Thomas...

Read More